Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRSH vs GSK✓SelectedUSD · GSKMRSH vs GSK performance historyLatest closeAs of-0.37%11/19
Stock and ETF performance explorer

MRSH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,813.7%
GSK return
+1,646.5%
Excess return
+2,167.2%
Maximum drawdown
-67.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%-1.6%+1.2%+0.1%
7D-0.5%-4.7%+4.2%+1.1%
30D+7.0%-4.7%+11.7%+8.6%
3M+8.8%-8.8%+17.6%+11.9%
6M+24.7%-4.6%+29.3%+26.2%
YTD+12.7%+1.0%+11.7%+11.3%
1Y+18.1%+6.9%+11.2%+14.4%
3Y+9.0%+52.5%-43.6%-8.1%
5Y+31.0%+40.3%-9.3%+12.1%
10Y+250.2%+99.0%+151.3%+163.9%
All+3,813.7%+1,646.5%+2,167.2%+1,631.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling